These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 173386)

  • 41. Incidence of serum antibody titers against herpes simplex virus in Japanese patients.
    Miyachi M; Imafuku S
    J Dermatol; 2017 Jan; 44(1):47-51. PubMed ID: 27401119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Herpes simplex virus vaccines.
    Wise TG; Pavan PR; Ennis FA
    J Infect Dis; 1977 Nov; 136(5):706-11. PubMed ID: 199677
    [No Abstract]   [Full Text] [Related]  

  • 43. Herpes simplex antigen in immune complexes of patients with erythema multiforme: presence following recurrent herpes simplex infection.
    Kazmierowski JA; Peizner DS; Wuepper KD
    JAMA; 1982 May; 247(18):2547-50. PubMed ID: 6279897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered immunologic specificity of cells infected with Herpes simplex virus: recognition of human antiserum.
    Schwartz J; Elizan TS
    Z Immunitatsforsch Exp Klin Immunol; 1975 Feb; 148(4):291-8. PubMed ID: 170750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer cytotoxicity and antibody dependent cellular cytotoxicity in human herpes simplex virus infection.
    Hristescu S; Sahnazarov N; Muţiu A; Olinescu A
    Arch Roum Pathol Exp Microbiol; 1987; 46(4):333-46. PubMed ID: 2845886
    [No Abstract]   [Full Text] [Related]  

  • 47. Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis.
    Møller-Larsen A; Haahr S; Black FT
    Infect Immun; 1978 Nov; 22(2):445-51. PubMed ID: 730366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-mediated and humoral immune responses to herpes simplex virus and cytomegalovirus in renal transplant patients.
    Haahr S; Møller-Larsen A; Andersen HK; Spencer ES
    J Clin Microbiol; 1979 Sep; 10(3):267-74. PubMed ID: 226563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo.
    Voss LM; David CS; Showalter SD; Paya CV; Leibson PJ
    Int Immunol; 1992 Mar; 4(3):417-20. PubMed ID: 1314641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine.
    Straus SE; Savarese B; Tigges M; Freifeld AG; Krause PR; Margolis DM; Meier JL; Paar DP; Adair SF; Dina D
    J Infect Dis; 1993 May; 167(5):1045-52. PubMed ID: 8387560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological studies of herpes simplex virus infection in children with atopic eczema.
    Goodyear HM; McLeish P; Randall S; Buchan A; Skinner GR; Winther M; Rolland J; Morgan G; Harper JI
    Br J Dermatol; 1996 Jan; 134(1):85-93. PubMed ID: 8745891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Some immunological characteristics of subjects suffering from frequent herpes simplex virus recrudescences.
    Doutlík S; Kutinová L; Benda R; Kamínková J; Krcmár M; Votruba T; Suchánková A; Vonka V; Vacek Z
    Acta Virol; 1989 Sep; 33(5):435-46. PubMed ID: 2576584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular immunity and herpesvirus infections in cardiac-transplant patients.
    Rand KH; Rasmussen LE; Pollard RB; Arvin A; Merigan TC
    N Engl J Med; 1977 Jun; 296(24):1372-7. PubMed ID: 193008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening of antibodies to Herpes simplex virus in human sera by indirect immunofluorescence.
    Rajcáni J; Ravingerová E; Kocisková D; Szántó J
    Acta Virol; 1973 Jan; 17(1):61-8. PubMed ID: 4405398
    [No Abstract]   [Full Text] [Related]  

  • 55. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie S; Maingay J; Neill WA
    Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serological responses to herpes simplex virus type 1 (HSV-1) analysed with enzyme-linked immunosorbent assay (ELISA) and western blot (WB).
    Rabie-Finger H; Valentine-Thon E; Steinmann J; Nehrkorn A
    Acta Virol; 1991 Apr; 35(2):113-26. PubMed ID: 1681709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental immunosuppression induced by herpes simplex virus.
    Cappel R; Henry C; Thiry L
    Arch Virol; 1975; 49(1):67-72. PubMed ID: 172950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.
    Czarnetzki BM; Macher E
    Arch Dermatol Res; 1980; 268(3):247-55. PubMed ID: 7212769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Status of antiviral immunity in patients with recurrent herpes].
    Semenova TB; Posevaia TA; Karpovich LG; Bukovskaia SN; Blokha VV
    Vestn Dermatol Venerol; 1987; (6):43-7. PubMed ID: 2820161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.